PCVX · NASDAQ
Vaxcyte (PCVX) Stock Price & Fundamentals
Vaxcyte (PCVX) closed at $667.39 on Oct 9, 2026, up 0.66% from the previous close of $662.99.
Share price, past year
1Y −5.81%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $667.39 |
| Sep 30, 2026 | $659.73 |
| Aug 31, 2026 | $704.42 |
| Jul 31, 2026 | $679.80 |
| Jun 30, 2026 | $637.26 |
| May 29, 2026 | $600.27 |
| Apr 30, 2026 | $601.35 |
| Mar 31, 2026 | $631.04 |
| Feb 27, 2026 | $646.85 |
| Jan 30, 2026 | $651.18 |
| Dec 31, 2025 | $670.75 |
| Nov 28, 2025 | $702.86 |
| Oct 31, 2025 | $696.32 |
Key statistics
- Market cap
- $96.63B
- EPS (TTM)
- −$7.64
- Net income (TTM)
- −$1.06B
- Shares outstanding
- 144.8M
- 52-week range
- $594.29 – $717.65
Vaxcyte's market cap is $96.63B, based on a share price of $667.39 and 144.8M shares outstanding as of Jun 30, 2026.
Financials
Vaxcyte's SEC filings don't report revenue in the standard form Laurel reads, so its revenue history isn't shown yet.
Vaxcyte reported a net loss of $766.63M in fiscal 2025.
Company profile
- Name
- Vaxcyte, Inc.
- Ticker
- PCVX
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Biological Products, (No Diagnostic Substances)
- Headquarters
- 825 Industrial Road, Ste. 300, San Carlos, CA 94070
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001649094
Recent SEC filings
- Oct 5, 2026
- Sep 3, 2026
- Aug 5, 2026
- Aug 5, 2026
- Jul 15, 2026
- Jun 23, 2026
- Jun 16, 2026
- May 6, 2026
Frequently asked questions
What is Vaxcyte's stock price?
Vaxcyte (PCVX) closed at $667.39 on Oct 9, 2026, up 0.66% from the previous close of $662.99.
What is Vaxcyte's market cap?
Vaxcyte's market cap is $96.63B, based on a share price of $667.39 and 144.8M shares outstanding as of Jun 30, 2026.
Does Vaxcyte pay a dividend?
Yes. Vaxcyte declared $0.00 per share in dividends for fiscal 2025.
Sources and methodology
Fundamentals come from Vaxcyte, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures